Phreesia, Inc. (NYSE:PHR) Shares Purchased by Sei Investments Co.

Sei Investments Co. grew its stake in shares of Phreesia, Inc. (NYSE:PHR) by 8.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 196,815 shares of the company’s stock after purchasing an additional 15,241 shares during the quarter. Sei Investments Co.’s holdings in Phreesia were worth $4,952,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Intech Investment Management LLC purchased a new stake in shares of Phreesia during the third quarter valued at approximately $316,000. Charles Schwab Investment Management Inc. lifted its holdings in Phreesia by 3.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock worth $10,193,000 after buying an additional 16,112 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock valued at $637,000 after buying an additional 905 shares during the last quarter. MetLife Investment Management LLC lifted its stake in shares of Phreesia by 3.8% in the third quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock worth $701,000 after acquiring an additional 1,120 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Phreesia by 9.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,015 shares of the company’s stock valued at $319,000 after purchasing an additional 1,258 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on PHR shares. Citigroup upped their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. KeyCorp raised their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia presently has a consensus rating of “Buy” and an average price target of $31.33.

Insider Buying and Selling

In other Phreesia news, COO Evan Roberts sold 2,873 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $76,450.53. Following the sale, the chief operating officer now directly owns 779,993 shares in the company, valued at approximately $20,755,613.73. The trade was a 0.37 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $25.32, for a total transaction of $88,518.72. Following the transaction, the general counsel now owns 139,134 shares of the company’s stock, valued at approximately $3,522,872.88. This trade represents a 2.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 164,269 shares of company stock valued at $4,661,469 over the last quarter. Corporate insiders own 5.80% of the company’s stock.

Phreesia Trading Down 0.4 %

Shares of NYSE:PHR opened at $25.46 on Wednesday. The company has a 50 day moving average of $27.31 and a 200-day moving average of $24.21. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.50 billion, a P/E ratio of -17.32 and a beta of 1.03. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.